Review highlights how chemical probes reveal the functions of orphan nuclear receptors, suggesting new therapeutic directions.
Nuclear receptors (NRs) are ligand-regulated transcription factors that control many physiological processes, from metabolism and inflammation to development and circadian rhythms. Beginning in the 1990s, systematic chemical probe development transformed many 'orphan' NRs with unknown endogenous ligands into chemically tractable, well-studied molecular targets, uncovering their physiological functions and potential for therapeutic development. The present review examines how small molecule ligands for peroxisome proliferator-activated receptors, liver X receptors, farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor enabled the scientific community to connect orphan NR activation to specific transcriptional programs, metabolic phenotypes, and disease processes-while emerging tools for liver receptor homolog-1/steroidogenic factor-1, Rev-Erbs, nerve growth factor-induced clone Bs, HNF4, and transcription factor tailless hold promise to do likewise. These tools not only had widespread impact on NR biology but also established many design principles for chemical probes that continue to guide the field today. The NR field demonstrates how systematic chemical probe discovery can enable basic research and de-risk therapeutic hypotheses, providing a roadmap for other chemical probe initiatives in the human proteome.
No takes yet. Share an insight, caveat, or question.
Willson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: